SciELO - Scientific Electronic Library Online

 
vol.11 issue4Characterization of victims of accidents and violence: emergency Service of Alta Floresta - MT (Brazil)Profiles of early neonatal deaths: a study for a Public Maternity Hospital of Belo Horizonte (MG), 2001 - 2006 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Epidemiologia

Print version ISSN 1415-790XOn-line version ISSN 1980-5497

Rev. bras. epidemiol. vol.11 no.4 São Paulo Dec. 2008

http://dx.doi.org/10.1590/S1415-790X2008000400013 

ORIGINAL ARTICLES

 

Analysis of hospitalizations of children under one year of age due to drug intoxication and adverse events in Brazil

 

 

Marise de Araújo LessaI; Rosany BochnerII

IInstitutional Program for Scientific Initiation Scholarships of the CNPq / Institute of Scientific & Technological Communications and Information in Health (ICICT) - Oswaldo Cruz Foundation
IIInstitute of Scientific & Technological Communications and Information in Health (ICICT) - Oswaldo Cruz Foundation

Corresponding author

 

 


ABSTRACT

The widespread use of drugs without medical prescription, nearly always ignoring the adverse events they may cause, is the leading factor accounting for human intoxications registered in Brazil. Children are the greatest victims of self-medication, administration errors, inappropriate medical prescription, lack of appropriate studies on the safe use of medicines in this age group, in addition being susceptible to accidental ingestion driven by the curiosity natural to their age. The present study aims to identify the main therapeutic classes involved in drug intoxications or adverse events related to the hospitalization of children under one year of age, registered by the Hospital Information System of the Unified Health System in the years 2003-2005. A total of 1,063 hospitalizations were analyzed, 151 of them involving children aged less than one month old and 912 children aged 1-11 months. Sedative-hypnotics accounted for 15.2% of hospitalizations related to drug intoxication and adverse effects in children less than one month old, and for 21.2% of such events in children aged 1-11 months. Antibiotics accounted for 12.6% and 18.9% of hospitalizations in the same age groups, respectively. Analgesics/antipyretics had a smaller share, with 7.3% of hospitalizations in the group under 1 month and 6.7% in the group aged 1-11 months. A great number of cases were observed on zero day old children, leading us to consider possible intoxications through the placenta or nursing. Therefore, this study points toward the importance of good antenatal care, as well as the necessary extra attention when prescribing drugs to both mothers and infants.

Keywords: Intoxication. Medication. Hospitalization. Infancy.


 

 

Introduction

Modern society attributes high value to the consumption of medications in daily life. Many people actually believe they are buying "health" over the counter top.

The market constantly offers therapeutic novelties, and some drugs that are already on the market get new indications. These facts contribute to a significant increase in non-rational use of medications1.

The population is under pressure from several sectors to consume an increasing amount of the medications that are on the market, such as from the pharmaceutical industry, advertising agencies, and communication companies2. In 2002, according to data published by the National Health Surveillance Agency (ANVISA), there were 15,831 drugs being marketed in Brazil, and the total volume of drug units marketed in the retail market reached 1,277,336,6353. Such an excessive consumption increased the number of intoxications and adverse effects; after all, it is a well-known fact that all drugs pose potential risks4.

Arrais et al.5, while investigating the self-medication profile in Brazil, collected data that support the hypothesis of current society's naïve and excessive belief in the power of medications. This contributes to the increasing demand for pharmaceutical products to treat any type of ailment, no matter how ordinary or self-limited. Many are used without medical indications, leading to countless cases of intoxication. Children are part of this reality. According to a study carried out by Silva et al.6, there is a high level of medication consumption in nearly all age groups. This study also reveals that, in the absence of medical guidance, the mother is the main adviser for medication consumption.

Data of the National Toxicopharmacological Information System - SINITOX7 for the 2003-2005 period indicate that children aged less than five years are the main victims of drug intoxication (31.8%). Children aged less than a year do not stand out in intoxication rates (3.4%); however, their morbidity coefficient is high, 23.2 per 100,000 inhabitants, only lagging behind the coefficient of children aged one to four years: 46.6. According to Schvartsman8, when one considers the pediatric age group, acute intoxications stand out. Among children aged less than a year, medications account for 60% of the intoxications, twice the general population's rate.

Considering the importance of drug intoxications among children aged less than a year and given that this age group is poorly explored in the literature, the main groups of drugs involved in hospitalizations related to intoxications and adverse effects in this age group may be identified by associating them to the age of children, subdivided in days and months and with the possible causes to justify them.

 

Methods

The study's design is retrospective, and it covers hospitalizations registered in Brazil by the SUS Hospital Information System (SIH-SUS) from 2003 to 2005. The source of the data are the SUS Hospitalization Authorization Movement CD-ROMs9,10,11.

"Cases" of hospitalization of children aged less than one year presenting, as the main and/or secondary diagnosis, codes related to intoxication by medications or to adverse effects of medications, according to the 10th Revision of the International Classification of Diseases (ICD-10)12, were considered, as detailed in Chart 1.

Codes X42, X62, and Y12 were suppressed in order to avoid the selection of codes from the ICD-10 that would not allow for the distinction between complications associated with the use of medications and those caused by the use of licit and illicit drugs. This approach was also adopted by Rozenfeld13, when performing a wider-ranging study on the complications caused by drugs in hospitals in the State of Rio de Janeiro.

To perform the descriptive data analysis, cases were divided into two groups. The first included children aged less than a month, with ages represented in days, while the second, children aged one to 11 months, with ages represented in months.

The analysis considered four situations caused by possible main and secondary diagnoses presented by case studies, as detailed in Chart 2. Situation one suggests the child was hospitalized for a reason other than the one we are considering in this study, but who, when treated, ended up turning into a case, that is, there are signs that the drug intoxication or adverse effect occurred in the hospital. Situation 2 suggests the child was being medicated outside the hospital to treat the cause of the secondary diagnosis, and such treatment ended up causing an adverse effect due to the therapeutic use of the medication, i.e., an adverse reaction or even an intoxication, which might have occurred due to circumstances such as administration errors, inappropriate indications, use without medical prescription but by layman indication. The circumstances involved are not made very clear by the data, given the ICD-10 codes that bring this information are in chapter 20, which, in turn, is used to fill-in the secondary diagnosis, and not the main one, as it is the case in this situation. Situation 3 also suggests the child was not in the hospital when a case of intoxication or adverse effect caused by medication happened. Since there is no description of the pathology associated to the use of the medication, it is more likely the event occurred accidentally. However, this situation may point toward more information on the circumstances of the incident, if the secondary diagnosis is duly filled-in with the codes of chapter 20 listed in Chart 1. Situation 4 also suggests the child was not in the hospital when it became a case. This is the situation that offers the least information, as it does not present data on the secondary diagnosis and, thus, on the circumstances of the event. All of these situations must be interpreted carefully for children aged zero day, as well as for those aged one or two days who were already in the hospital due to their birth, when the medication-related intoxication or adverse effect occurred.

 

 

The circumstances of the event is considered in two ICD-10 chapter 19 codes regarding adverse effects (T88.6 and T88.7) and in ICD-20 chapter 20 codes regarding the other circumstances, as well as adverse effects (X40-X44, X60-X64, X85, Y10-Y14, and Y40-Y57), as defined in Chart 1. So, only the hospitalizations that used these codes to define the main or secondary diagnosis could have their circumstances described by one of the following categories: accident, aggression, self-intoxication, adverse effect, and undetermined. The "ignored" category was selected for the others.

According to the specified circumstanced or based on a few codes presented for the main and/or secondary diagnosis, when the circumstance is ignored, cases were classified as intoxications or adverse effects, as described in Chart 3.

 

 

The procedures that were performed were classified in two groups. The first one regarded specifically drug intoxication, while the second one regarded the other procedures adopted to treat cases. The relationship between these two groups of procedures and the four above-mentioned situations was also taken into account during data analysis.

The therapeutic classes can be better detailed for hospitalizations in which the main or secondary diagnosis has been filled-in with the four digits foreseen by chapter 19 codes and for the Y40 to Y57 groupings of chapter 20 of the ICD-10, as described in Chart 1. However, due to the widespread use of digits 8 and 9, related to the "other" and "non-specified" categories, the results found for certain substances cannot be representative and, thus, will not be explored.

A table (Tables 1 & 2) has been prepared for each of the age groups relating the four situations described above to the variables of age, gender, circumstances, case classification, procedure carried out, and therapeutic class. Lethality was calculated for each variable category, in addition to the four situations. Ages were grouped as follows: 0 day, 1 to 7 days, 8 to 14 days, 15 to 21 days, and 22 to 29 days for the group of children aged less than 1 month, and 1 month, 2 to 3 months, 4 to 5 months, 6 to 7 months, 8 to 9 months, and 10 to 11 months, for the group of children aged 1 to 11 months.

To analyze the main therapeutic classes involved in the cases classified as intoxication or adverse effect, a table (Table 3) has been prepared to show the number of cases and the therapeutic class percentages for each of the case classifications, considering the group of children aged less than 1 month and the group of those aged 1 to 11 months separately.

To test the independence between the different age groups considered in the study and the situation variables, case circumstances and classification, a chi-square test was applied with a 5% level of significance14.

To test if there is any difference among the situations based on age and on the length of stay, the Kruskal-Wallis non-parametric test was applied, since the assumptions of variance normality and homogeneity were not complied with, and these are required in order to apply a more powerful, better known parametric test, the Analysis of Variance (ANOVA)14.

To test differences between cases classified as "intoxication" or "adverse effect," based on the ages and on the length of hospitalization, the Wilcoxon-Mann-Whitney non-parametric test was applied, since the assumptions of normality and homogeneity were not complied with, as required to apply the parametric t test14.

The project was approved by the Committee for Ethics in Research on Human Beings of Fundação Oswaldo Cruz's (Fiocruz) Evandro Chagas Clinical Research Institute (IPEC), under opinion report No. 028/2008.

 

Results

Overall, 1,063 hospitalizations of children aged less than a year related to drug intoxications and adverse effects, between 2003 and 2005, were analyzed.

Table 1 shows age distribution in days, gender, procedure carried out, circumstances, case classification, and therapeutic class according to the situation of the 151 cases and 2 deaths during the hospitalizations of children aged less than a month related to intoxications and adverse effects of medications, as well as lethality for all of the categories of these variables. The major concentration of these cases among zero-day children (31.8%), as well as in situation one (45.0%) is remarkable. However, it is noteworthy that in this situation, 64.7% of the cases involve a single therapeutic class, enzymes (Y43.6). In the analysis of the procedure that was carried out, situation one is observed as differing from the other ones, as it concentrates its data per medication. Among the 103 cases with non-ignored circumstances, adverse effects accounted for most cases (56 - 54.4%), followed by accidents (29 - 28.2%). However, the circumstances of the event could only be analyzed for situations one and three. In 31.8% of hospitalizations, circumstances are ignored. Adverse effects accounted for most (51 - 76.1%) of the 67 cases of situation one with non-ignored circumstances, while for the 36 cases of situation three with non-ignored circumstances the accidental category appeared in more than half of the cases (21 - 58.3%). Concerning the 151 hospitalizations of children aged less than one month, 95 were classified as cases of intoxication (62.9%) and 56 as adverse effects (37.1%). The two deaths occurred in situation one, involving boys aged eight and 27 days. The lethality observed by the study for this age group was 1.32%. However, lethality for situation one is higher, 2.94%, a fact that can be an indicator of case severity, something that may be relative on account of the small number of deaths registered. Although enzymes are present in a larger number of cases (44 - 29.1%), their participation is not limited to situation one and to the cases classified as adverse effects. The therapeutic class represented by other drugs, medications and biological substances and non-specified factors is listed in 33 cases (21.9%), appearing in situations one, two, and three, accounting for 16.2%, 25.0% and 38.9%, respectively. The anti-epileptic, sedative-hypnotic and antiparkinsonian drugs were present in 23 cases (15.2%), and although appearing in all situations, they concentrate in situation four (15 cases - 65.2%). The antibiotics listed in 19 cases (12.6%) were only registered for situations two and three. Analgesics, antipyretics and non-opiate anti-rheumatics, listed in 11 cases (7.3%), are present in situations one, two, and three.

Table 2 shows the distribution of age, in months, gender, procedure performed, circumstances, case classification, and therapeutic class per situation of the 912 cases and 10 deaths during hospitalization of children aged one to 11 months, as related to intoxications and adverse effects of medications. It is noteworthy that beginning with the two-to-three-month age group, the number of cases decreases, until the 10-to-11-month age group, when it increases. Situations two and three stand out, adding up to 559 cases (61.3%), but with a lethality of only 0.36%. Of the 10 deaths, six occurred in situation one, two in situation two, and two in situation four, 7 of which in males and 3 in females. The lethality observed for this age group was 1.10%, below that of the group of children aged less than one month (1.32%). However, lethality for this group with regard to situation one is above the one observed for the group of children aged less than one month, 3.21% compared to 2.94%. Lethality differences per gender and per case classification are especially noteworthy, with deaths associated to males and adverse effect being twice greater than those associated to females and intoxication. In 49.1% of hospitalizations, circumstances are ignored, a figure that is higher than that seen for children aged less than one month (31.8%). Of the 464 cases of non-ignored circumstances, most were accidents (44.8%), followed by adverse effects (24.4%). Accidental circumstances are more present in situation three, in which out of 270 cases with non-ignored circumstances, 135 were accidental (50.0%). For situation one, the percentage of accidental and adverse effect circumstances were closer, 39.8% and 29.3%, respectively. Of the 912 hospitalizations of children aged 1 to 11 months, 786 were classified as cases of intoxication (86.2%), while 126 as adverse effects (13.8%). The therapeutic class represented by other drugs, medications, and biological substances, in addition to the non-specified ones, is listed for 294 cases (32.2%), appearing in situations one, two and three, accounting for 54.0%, 31.5% and 37.7%, respectively. The anti-epileptic, sedative-hypnotic and antiparkinsonian classes were present in 191 cases (21.1%), systemic antibiotics in 169 hospitalizations (18.5%), and analgesics, antipyretics and non-opiate anti-rheumatic, with a smaller participation, appear in 60 cases (6.6%).

Table 3 shows the distribution of the cases and the percentages of the main therapeutic classes for the cases classified as intoxication and as adverse effects, for the two groups of children, aged less than one month, and from 1 to 11 months. It can be seen that cases classified as adverse effects do not have the same distribution for the therapeutic classes as those listed as intoxication. For the group of children aged 1 to 11 months, the low participation of anti-epileptic, sedative-hypnotic and antiparkinsonian substances in adverse effect cases stands out, 2.4%, as does the small participation of systemic antibiotics, 5.6%, compared to the involvement of the same therapeutic classes for cases of intoxication, 24.0% and 20.6%, respectively. Also based on this group of children and on the cases classified as adverse effects, the class of hormones, their synthetic substitutes and their antagonists can be seen as the one with the second highest percentage participation (7.1%), only lagging behind other and non-specified drugs (42.1%).

Considering the group of children aged less than one month, no significant differences were seen between ages and the time patients remained hospitalized while comparing situations, circumstances, and classifications.

Regarding the group of children aged 1 to 11 months, when applying the Kruskal-Wallis test, significant differences were seen in the time the patient remained hospitalized when comparing the four situations (p-value = 0.0038), and it was situation one that had the highest average (4.4 days). With regard to case classification, the average time patients remained hospitalized for those classified as adverse effects was 3.6 days, while 2.9 days for those rated as intoxication. However, the Wilcoxon-Mann-Whitney test concluded this time is not any longer than that involved in cases classified as adverse effects (p-value = 0.0761).

During the analysis of children aged less than a month, all 44 hospitalizations related to code "Y43.6 - Adverse effect of enzymes, not classified elsewhere" (29.1%) were observed to have occurred in the State of São Paulo, at the same hospital, identified by the information contained in the SUS Hospital Information System database (SIH-SUS). These cases were seen in all of the years of the study, with an increasing trend: six cases in 2003, 13 in 2004 and 25 in 2005. Code Y43.6 appeared as a secondary diagnosis, while the primary diagnosis for 86.4% of the cases involved codes "P58 - Neonatal jaundice due to other excessive haemolysis" and "P59 - Neonatal jaundice from other and unspecified causes." In the analysis of the procedures carried out during these 44 hospitalizations, neonatal jaundice appears again, in 77.3% of the cases. The age group varied from 2 to 23 days, with 43 of the infants aged 2 to 13 days. The gender distribution was 25 boys and 19 girls. The time the patient remained hospitalized ranged from 1 to 24 days, with 95.4% of the cases lasting less than seven days. No deaths were registered in this case.

Another piece of information the study identified was the correlation between intoxication caused by medications and falls. Overall, 101 cases were identified as involving this association, 12 among children aged less than a month, and 89 among those aged 1 to 11 months. It is important to emphasize that in these cases, the fall was associated to the secondary diagnosis, while the intoxication or the adverse effect to the primary one (situation 2), leading to the hypothesis that the first event was the fall, which, when treated, ended up intoxicating the child and caused the need for hospitalization. The use of systemic antibiotics, including unspecified, macrolides, penicillin, antifungal antibiotics, among others, was associated to 42.6% of these 101 cases. For the group of children aged less than one month, this percentage was 33.3%, while for those aged 11 months it was 43.8%. The age group most affected by this type of relation was that of zero-day aged children, representing 50% of the 12 hospitalizations registered for the group of children aged less than one month and those aged 10 to 11 months, who represented 40.4% of the 89 hospitalizations in the group aged 1 to 11 months. Gender distribution was 3 boys and 9 girls aged less than one month, and 47 boys and 42 girls aged 1 to 11 months. No deaths were registered here either.

 

Discussion

It must be emphasized that the cases of drug intoxication and adverse effects covered in this study derive from hospitalizations and, thus, are presumably more severe. As such, comparisons to data derived from other sources must be made with great care.

The 48 hospitalization records of zero-day-old children bring up questions ranging from the quality of the record at such an age to the causes of drug intoxication or adverse effects at such a tender age. Few drugs are able to reach the fetus through the placenta, or the newborn through breastfeeding. In this context, it is important to value the quality of prenatal exams offered in the country, warning pregnant women of the importance of not using any unprescribed medication, as this can put their fetuses at risk. This warning must also be made during the breastfeeding period. Regarding quality of data, there is a significant loss of information when recording the age of children aged less than one day as zero day, instead of specifying the number of hours, as the system calls for. Such information would be very useful to explain the cause of intoxication. With regard to causes, vertical intoxication could explain the appearance of a few therapeutic classes such as anti-epileptic, sedative-hypnotic and antiparkinsonian drugs (9 cases - 18.8%) and psychotropics (2 cases - 4.2%) in this age group.

The fact that all 44 enzyme-related hospitalizations occurred at the same hospital in São Paulo was reported to the state's health surveillance. It is necessary to investigate if there were problems related to the application or even to the lot of enzymes. Errors made while filling in Hospitalization Authorizations (HA) cannot be ruled out and also demand investigation. Additionally, this finding causes these events to be considered "atypical" compared to the national context, and can generate biases in the analyses. An example of this can be noticed in the fact that the lethality of situation one obtained for the group of children aged less than one month (2.94%) was lower than lethality observed for the group of children aged 1 to 11 months (3.21%). However, if we do not consider the 44 enzyme-related cases, the lethality for the group of children aged less than one month goes up to 8.33%. Additionally, the chi-square test was not used to determine the independence between the age and situation, circumstance and case classification variables, since it showed distinct results when these 44 hospitalizations were or were not considered.

Of the 10 deaths registered among children aged 1 to 11 months, three occurred at the same hospital in the state of São Paulo, two in situation one and one in situation two. This result also deserves investigation by the state's health surveillance.

For the group of children aged less than one month, the therapeutic class represented by other drugs, medications, and biological substances, in addition to the unspecified ones added up to 21.9% of the cases. Meanwhile, for the group of children aged 1 to 11 months, this class accounted for 32.2%, a percentage that would be even higher if we considered only the cases rated as adverse effects, 42.1%. Since this therapeutic class represents the fact that the medication involved in the case is unknown, it can be inferred that the greater its share, the worse the quality of the information. In this way, while on one hand it is not hard to admit, as data suggest, that with the increase in age, the participation of this therapeutic class increases; on the other hand it is more intuitive to believe that a case rated as an adverse reaction would, theoretically, bring more information about the medication than one involving intoxication. However, data show exactly the opposite, a fact that requires more investigation.

Considering the group of children aged 1 to 11 months, the chi-square test indicated non-independence between the 1 to 9 month and the 10 to 11 month age groups with regard to the 4 situations pointed to previously (p-value = 0.0209). For children aged 10 to 11 months, the frequency observed for situation one is above expected, while the opposite occurs for situation three. This behavior disagrees with the hypothesis that the 10 to 11 month range accidental intoxication cases increase, since this is when the child gains mobility and is capable of crawling (Behrman et al.15) and, as such, could reach poorly stored medications. These incidents would be connected to situations three and four and not to situation one. Also going against this assumption, no relationship was seen between the 1 to 9 month and the 10 to 11 month age groups and the classification of the case as intoxication or adverse effect (p-value = 0.6075). However, this behavior can be justified by the limited movement of these children, who cannot reach medications yet or, even if they do reach them, the intoxications can result in less severe cases that do not require hospitalization. Another issue to be discussed is that the accidental circumstance, according to the ICD-10, considers, in addition to accidents, other non-intentional causes such as errors of administration, inappropriate medical prescriptions, undue use and abstinence, rendering it difficult to analyze the impact of the 10 to 11 month age group.

Self-medication, as lay medication administered by parents without medical prescription, is an intentional circumstance and should not be considered accidental. For this reason, it is believed that the self-intoxication circumstance presented by ICD-10 should include intentional circumstances such as abuse, attempted suicide, attempted abortion, and self-medication and lay medication. This fact would explain the 24 cases of self-intoxication that occurred in situation three, outside the hospital environment. The 18 cases of self-intoxication related to situation one call for further reflection on the previous inference drawn from the fact that all cases rated in situation one occurred in the hospital; and a careful analysis of the quality of the records of these 18 cases should be made.

The care taken while filling in the secondary diagnosis for situations one, three and four, measured by the number of non-ignored circumstances, revealed to be higher for the group of children aged less than one month. An assumption yet to be tested with new studies is the loss of the quality of this information the older the child is.

It is important that all pediatric medications have their doses calculated properly based on the child's weight. According to Kaushal et al.16, the classes of medications that are often associated with dosage or even administration errors are anti-infectious, painkillers and sedatives. Pediatric patients are the ones who suffer the most with these errors.

There are ethical standards that prevent research using human subjects, particularly children. According to Meiners et al.17, many medications available in the market are used in an empirical, often questionable manner due to the lack of full research appropriate for pediatric patients. The proper dosages, the harmful drug interactions, and the side effects are unknown. Practice will provide these answers, but intoxications may occur in the meantime.

In an assessment of the prescriptions given to 51 children aged one month to 13 years, ICU patients at the Porto Alegre General Hospital, carried out between July and August 2002, 10.5% of the medications used were non-approved, while 49.5% of them were non-standardized. All patients considered in this study had at least one non-standardized medication prescribed to them18.

About 80% of the medications prescribed for children in the United States are not approved by the FDA (Food and Drug Administration) for use in this age group19.

A study carried out in a hospital for children in the Netherlands also showed countless unlicensed drugs being prescribed to treat this age group, and many licensed medications are used in a way other than that they were regulated for use for (off-label)20.

According to Pizzol et al.21, in Brazil it is easy to have access to medications, both due to the large number of pharmacies and drugstores available, and because of the ethically and legally questionable commercial practices carried out by several establishments. The population must be warned about the harm caused by uncontrolled medication consumption.

 

Conclusion

In the period between 2003 and 2005, 1,063 children aged more than a year were hospitalized in public or private hospitals holding agreements with the public healthcare system in the country as a direct or indirect consequence of drug intoxication or adverse effects.

There were more cases of intoxication than adverse medication effects, both for the group of children aged less than one month and for that of children aged 1 to 11 months.

When working with children aged less than one year, accidental intoxications caused by the children themselves, so common in the 1 to 4 year old group, practically do not appear in this study.

The main causes underlying hospitalizations of children aged less than one year related to intoxication by medications were: administration errors, inappropriate medical prescriptions, medication administration by caretakers and without medical guidance, abstinence, and, above all, the maternal use of medications, with or without medical guidance, which ends up intoxicating the child, whether through the placenta or via breastfeeding.

Consequently, the study calls for special strategies to solve these incidents, including reflections on the rational use of medications in children aged less than one year, providing guidance for parents and healthcare workers, better prenatal care, and more attention in the first months of life with regard to the medications dispensed to mothers and children.

 

References

1. Castro CGSO. Estudos de utilização de medicamentos: noções básicas. Rio de Janeiro: Editora Fiocruz; 2000.         [ Links ]

2. Nascimento AC, Sayd JD. "Ao persistirem os sintomas, o médico deverá ser consultado". Isto é regulação? Rev Saúde Coletiva 2005; 15(2): 305-28.         [ Links ]

3. Organização Pan-Americana da Saúde. Avaliação da assistência farmacêutica no Brasil. Brasília: OPAS/Ministério da Saúde; 2005.         [ Links ]

4. Nascimento MC. Medicamentos: ameaça ou apoio à saúde? Rio de Janeiro: Editora Vieira e Lent; 2003.         [ Links ]

5. Arrais PSD, Coelho HLL, Batista MCDS, Carvalho ML, Righi RE, Arnau JM. Perfil da automedicação no Brasil. Rev Saúde Pública 1997; 31(1): 71-7.         [ Links ]

6. Silva CH, Giugliani ERJ. Consumo de medicamentos em adolescentes escolares: uma preocupação. J Pediatria 2004; 80(4): 326-32.         [ Links ]

7. Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Sistema Nacional de Informações Tóxico-Farmacológicas. Estatística Anual de Casos de Intoxicação e Envenenamento. Brasil, 2003, 2004, 2005. http://www.fiocruz.br/sinitox. [Acessado em 10 de setembro de 2007]         [ Links ].

8. Schvartsman C, Schvartsman S. Intoxicações Exógenas Agudas. J Pediatria 1999; 75: 244-50.         [ Links ]

9. Departamento de Informática do SUS (Datasus). Movimento de Autorização de Internação Hospitalar. Arquivos Reduzidos, 2003. CD-ROM. Brasília: Ministério da Saúde.         [ Links ]

10. Departamento de Informática do SUS (Datasus). Movimento de Autorização de Internação Hospitalar. Arquivos Reduzidos, 2004. CD-ROM. Brasília: Ministério da Saúde.         [ Links ]

11. Departamento de Informática do SUS (Datasus). Movimento de Autorização de Internação Hospitalar. Arquivos Reduzidos, 2005. CD-ROM. Brasília: Ministério da Saúde.         [ Links ]

12. Organização Mundial da Saúde. Ministério da Saúde. Universidade de São Paulo. Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde. Décima Revisão. Volume 1. São Paulo: EDUSP; 2004.         [ Links ]

13. Rozenfeld, S. Agravos provocados por medicamentos em hospitais do Estado do Rio de Janeiro, Brasil. Rev Saúde Pública 2007; 41(1): 108-15.         [ Links ]

14. Callegari-Jacques, SM Bioestatística. Princípios e Aplicações. Porto Alegre: Artmed; 2003.         [ Links ]

15. Behrman RE, Kliegman RM, Jenson HB. Nelson Tratado de Pediatria. 16ª edição. Rio de Janeiro: Editora Elsevier; 2005.         [ Links ]

16. Kaushal R, Bates DW, Landrigan C, ET AL. Medication errors and adverse drug events in Pediatric Inpatients. JAMA 2001; 285 (16): 2114-20.         [ Links ]

17. Meiners MMMA, Bergsten-Mendes G. Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade? Rev Assoc Méd Bras 2001; 47(4): 332-7.         [ Links ]

18. Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Trott EA. Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátrico. J Pediatria 2003; 79(5): 397-402.         [ Links ]

19. Kauffman RE. Essential drugs for infants and children: North American perspective. Pediatrics 1999; 104(3): 603-5.         [ Links ]

20. Jong GW, Vulto AG, Hoog M, Schimmel KJM, Tibboel D, Van Den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children's Hospital. Pediatrics 2001; 108(5): 1089-93.         [ Links ]

21. Pizzol TSD, Branco MMN, Carvalho RMA, Pasqualotti A, Maciel EM, Migott AMB. Uso não-médico de medicamentos psicoativos entre escolares do ensino fundamental e médio no sul do Brasil. Cad Saúde Pública 2006; 22(1): 109-15.         [ Links ]

 

 

Corresponding author:
Rosany Bochner
Fundação Oswaldo Cruz
Av. Brasil, 4365 - Prédio Haity Moussatché, 2º andar, sala 206
21045-900 - Rio de Janeiro RJ.
Phone: (21) 3865-3247
Fax: (21) 2290-1696
E-mail: rosany@cict.fiocruz.br

Funding: CNPq/FIOCRUZ

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License